| scholarly article | Q13442814 |
| P50 | author | Bilal Ustundag | Q125389570 |
| P2093 | author name string | Erdal Yilmaz | |
| Yasar Dogan | |||
| Saadet Akarsu | |||
| Metin Kaya Gurgoze | |||
| P2860 | cites work | Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus | Q77157791 |
| In vitro secretion of interleukin 2 and expression of IL-2 receptor in peripheral blood lymphocytes in high risk of insulin-dependent diabetes mellitus subjects | Q77311666 | ||
| Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study | Q77769452 | ||
| Multiple immuno-regulatory defects in type-1 diabetes | Q28344695 | ||
| Cytokines suppress human islet function irrespective of their effects on nitric oxide generation | Q34143253 | ||
| Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats | Q39759463 | ||
| TNF-alpha and insulin resistance: summary and future prospects | Q40857239 | ||
| RAGE: a novel cellular receptor for advanced glycation end products | Q41011414 | ||
| Alterations of in vitro interleukin 1 and 2 in diabetic children. | Q41327074 | ||
| Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes | Q42493190 | ||
| Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children | Q43889817 | ||
| Cytokine secretion is impaired in women with diabetes mellitus | Q44245284 | ||
| Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. | Q44480697 | ||
| Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes | Q44495268 | ||
| Soluble interleukin 2 receptor levels in children with type I insulin-dependent diabetes mellitus. | Q44819313 | ||
| Interleukin-6 (IL-6) and IGF-IGFBP system in children and adolescents with type 1 diabetes mellitus | Q45062395 | ||
| Cytokine profile in children during the first 3 months after the diagnosis of type 1 diabetes | Q47614059 | ||
| Decreased secretion of Th2 cytokines precedes Up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. | Q50849518 | ||
| Chemokines control fat accumulation and leptin secretion by cultured human adipocytes | Q57076426 | ||
| Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes | Q57716852 | ||
| Cytokine overproduction in healthy first degree relatives of patients with IDDM | Q59102192 | ||
| Low interleukin-2 synthesis by type 1 diabetics is regulated at the pretranslational level | Q68004825 | ||
| Acquired defect in interleukin-2 production in patients with type I diabetes mellitus | Q68903065 | ||
| TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide | Q71003660 | ||
| Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus | Q71008247 | ||
| Imbalance of the interleukin 2 system in children with IDDM | Q72119677 | ||
| Expression levels of IL-6 mRNA in PBMNCs from patients with IDDM, NIDDM and normals by RT-PCR procedure | Q72329527 | ||
| Low interleukin-2 receptor levels in serum of patients with insulin-dependent diabetes | Q72860300 | ||
| Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals | Q73251420 | ||
| Serum IL-1, IL-2, TNFalpha and INFgamma levels of patients with type 1 diabetes mellitus and their siblings | Q73313759 | ||
| Activated T lymphocytes from patients with high risk of type I diabetes mellitus have different ability to produce interferon-gamma, interleukin-6 and interleukin-10 and undergo anti-CD95 induced apoptosis after insulin stimulation | Q73413321 | ||
| Interleukin-1-beta, tumor necrosis factor-alpha, insulin secretion and oral glucose tolerance in non-diabetic siblings of children with IDDM | Q73691167 | ||
| Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications | Q73866692 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 59206 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children | |
| P478 | volume | 2006 |
| Q37598215 | Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes |
| Q27349718 | Altered Macrophage and Dendritic Cell Response in Mif-/- Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes |
| Q84775923 | Altered Toll-like receptor signaling pathways in human type 1 diabetes |
| Q58764994 | Amelioration effects of nanoencapsulated triterpenoids from petri dish-cultured on reproductive function of diabetic male rats |
| Q43514765 | Arterial stiffness is not increased in teens with early uncomplicated type 1 diabetes mellitus |
| Q41572131 | Association between IgE-mediated allergies and diabetes mellitus type 1 in children and adolescents |
| Q36711831 | Blocking type I interferon signaling rescues lymphocytes from oxidative stress, exhaustion, and apoptosis in a streptozotocin-induced mouse model of type I diabetes. |
| Q36552481 | Blood-based signatures in type 1 diabetes |
| Q40162151 | Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes. |
| Q46446914 | Cooked common beans (Phaseolus vulgaris) protect against β-cell damage in streptozotocin-induced diabetic rats |
| Q80559432 | Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation |
| Q38532367 | Differential control of muscle mass in type 1 and type 2 diabetes mellitus |
| Q52723663 | Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of disease. |
| Q36249702 | Dysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetes |
| Q41751738 | Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression |
| Q90079514 | Fucoxanthin-Rich Brown Algae Extract Improves Male Reproductive Function on Streptozotocin-Nicotinamide-Induced Diabetic Rat Model |
| Q34072307 | Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes |
| Q38235580 | Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases? |
| Q41692104 | Glucagon-like peptide-1 receptor agonist exendin-4 protects against interleukin-1β-mediated inhibition of glucose-stimulated insulin secretion by mouse insulinoma β cells |
| Q46379099 | Haptoglobin and the inflammatory and oxidative status in experimental diabetic rats: antioxidant role of haptoglobin |
| Q35757080 | Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat. |
| Q40703127 | Imbalanced Macrophage and Dendritic Cell Activations in Response to Candida albicans in a Murine Model of Diabetes Mellitus |
| Q35860851 | Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes |
| Q54353644 | Increased TLR2 expression in patients with type 1 diabetes: evidenced risk of microalbuminuria. |
| Q37399738 | Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus |
| Q36335960 | Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY). |
| Q35053311 | Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes |
| Q36225939 | Innate inflammation in type 1 diabetes |
| Q64080702 | Interleukin 6 Function in the Skin and Isolated Keratinocytes Is Modulated by Hyperglycemia |
| Q36788764 | Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset |
| Q37338915 | Interleukin-1 stimulates catabolism in C2C12 myotubes. |
| Q38706264 | Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes |
| Q35677591 | Lutein dietary supplementation attenuates streptozotocin-induced testicular damage and oxidative stress in diabetic rats |
| Q91963050 | Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes |
| Q39618192 | Modulatory effect of insulin on T cell receptor mediated calcium signaling is blunted in long lasting type 1 diabetes mellitus. |
| Q37405753 | Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells |
| Q35744426 | Non-cell autonomous influence of the astrocyte system xc- on hypoglycaemic neuronal cell death |
| Q36364298 | Offloading treatment is linked to activation of proinflammatory cytokines and start of bone repair and remodeling in Charcot arthropathy patients |
| Q34666831 | Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis |
| Q39249398 | Pancreatic islet inflammation: an emerging role for chemokines |
| Q37330708 | Polymorphic variant at the IL2 region is associated with type 1 diabetes and may affect serum levels of interleukin-2. |
| Q50130514 | Restoration of the type I IFN-IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice |
| Q33786938 | Serum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controls |
| Q42722361 | Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children |
| Q38797855 | Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis. |
| Q28566793 | Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise |
| Q36680316 | Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer. |
| Q35820734 | Th17 cells in human disease. |
| Q99711491 | The NLRP3 Inflammasome and Its Role in T1DM |
| Q28285897 | The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time |
| Q37542812 | The role of MIF in type 1 and type 2 diabetes mellitus |
| Q36679011 | The serum IL-6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes |
| Q37984231 | Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes |
| Q34693197 | Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes |
| Q38390695 | Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window |
| Q35062538 | Use of transcriptional signatures induced in lymphoid and myeloid cell lines as an inflammatory biomarker in Type 1 diabetes |
| Q33999020 | α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes |
Search more.